- Home
- RLMD vs NYC Comparison
RLMD vs NYC Comparison
Compare RLMD & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- NYC
- Stock Information
- Founded
- RLMD 2004
- NYC 2013
- Country
- RLMD United States
- NYC United States
- Employees
- RLMD N/A
- NYC N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- NYC Real Estate
- Sector
- RLMD Health Care
- NYC Finance
- Exchange
- RLMD Nasdaq
- NYC Nasdaq
- Market Cap
- RLMD 20.3M
- NYC 40.9M
- IPO Year
- RLMD N/A
- NYC N/A
- Fundamental
- Price
- RLMD $0.64
- NYC $13.25
- Analyst Decision
- RLMD Buy
- NYC
- Analyst Count
- RLMD 3
- NYC 0
- Target Price
- RLMD $5.00
- NYC N/A
- AVG Volume (30 Days)
- RLMD 211.8K
- NYC 3.4K
- Earning Date
- RLMD 08-11-2025
- NYC 08-08-2025
- Dividend Yield
- RLMD N/A
- NYC N/A
- EPS Growth
- RLMD N/A
- NYC N/A
- EPS
- RLMD N/A
- NYC N/A
- Revenue
- RLMD N/A
- NYC $58,397,000.00
- Revenue This Year
- RLMD N/A
- NYC $8.40
- Revenue Next Year
- RLMD N/A
- NYC $1.62
- P/E Ratio
- RLMD N/A
- NYC N/A
- Revenue Growth
- RLMD N/A
- NYC N/A
- 52 Week Low
- RLMD $0.24
- NYC $7.89
- 52 Week High
- RLMD $4.02
- NYC $16.30
- Technical
- Relative Strength Index (RSI)
- RLMD 50.91
- NYC 48.12
- Support Level
- RLMD $0.60
- NYC $13.12
- Resistance Level
- RLMD $0.74
- NYC $14.73
- Average True Range (ATR)
- RLMD 0.06
- NYC 0.84
- MACD
- RLMD 0.00
- NYC -0.27
- Stochastic Oscillator
- RLMD 44.19
- NYC 30.68
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.